95 related articles for article (PubMed ID: 16091481)
1. Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes.
Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
J Clin Endocrinol Metab; 2005 Oct; 90(10):5761-4. PubMed ID: 16091481
[TBL] [Abstract][Full Text] [Related]
2. No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.
Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
Atherosclerosis; 2007 Oct; 194(2):342-7. PubMed ID: 17141785
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
[TBL] [Abstract][Full Text] [Related]
4. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
[TBL] [Abstract][Full Text] [Related]
6. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
[TBL] [Abstract][Full Text] [Related]
7. Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men.
Duvillard L; Florentin E; Lalanne-Mistrich ML; Petit JM; Baillot-Rudoni S; Brun-Pacaud A; Brun JM; Gambert P; Vergès B
Diabetologia; 2005 Jul; 48(7):1366-72. PubMed ID: 15918022
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes.
Ruotolo G; Micossi P; Galimberti G; Librenti MC; Petrella G; Marcovina S; Pozza G; Howard BV
Metabolism; 1990 Jun; 39(6):598-604. PubMed ID: 2191189
[TBL] [Abstract][Full Text] [Related]
9. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K
Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886
[TBL] [Abstract][Full Text] [Related]
11. [Studies of influences of blood glucose controlling on the changes of lipid profiles, ApoB100, ApoAI and HDL subclass of newly diagnosed type 2 diabetes].
Tao S; Tian L; Fu M; Tian H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Apr; 30(2):368-74. PubMed ID: 23858765
[TBL] [Abstract][Full Text] [Related]
12. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
Bagdade JD; Dunn FL
Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
[TBL] [Abstract][Full Text] [Related]
13. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus.
Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
Diabetologia; 2000 Jan; 43(1):27-35. PubMed ID: 10663213
[TBL] [Abstract][Full Text] [Related]
14. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782
[TBL] [Abstract][Full Text] [Related]
15. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.
Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415
[TBL] [Abstract][Full Text] [Related]
16. Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study.
Duvillard L; Dautin G; Florentin E; Petit JM; Gambert P; Vergès B
J Clin Endocrinol Metab; 2010 May; 95(5):2140-6. PubMed ID: 20200333
[TBL] [Abstract][Full Text] [Related]
17. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
[TBL] [Abstract][Full Text] [Related]
18. Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery.
Selam JL; Kashyap ML; Gupta AK; Turner D; Wong ND; Lozano JL; Charles MA
Metabolism; 1994 Jun; 43(6):665-9. PubMed ID: 8201953
[TBL] [Abstract][Full Text] [Related]
19. A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.
Prinsen BH; Rabelink TJ; Romijn JA; Bisschop PH; de Barse MM; de Boer J; van Haeften TW; Barrett PH; Berger R; de Sain-van der Velden MG
Kidney Int; 2004 Mar; 65(3):1064-75. PubMed ID: 14871427
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
